Moleculin Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.57

-0.03 (-5.42%)

As of Sep 28, 10:40 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +4,369.2% upside

Low Target $14.54

Average Target $25.43

High Target $32.33

Current Price $0.57

Current
$0.57

Target
$25.43

$14.54 $25.43 avg $32.33

Scenario Analysis

Bear Case

$14.54

2,455.4%

Low target

Base Case

$25.43

+4,369.2%

Avg target

Bull Case

$32.33

+5,581.9%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$15.75

-96.4% from high

52-Week Low

$0.16

+252.5% from low

Target vs 52W High

$25.43

+61.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%